Your browser doesn't support javascript.
loading
Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.
Belhassen, Manon; Dalon, Faustine; Nolin, Maëva; Van Ganse, Eric.
Affiliation
  • Belhassen M; PELyon, PharmacoEpidemiology Lyon, 210 avenue Jean Jaurès, 69007, Lyon, France.
  • Dalon F; PELyon, PharmacoEpidemiology Lyon, 210 avenue Jean Jaurès, 69007, Lyon, France.
  • Nolin M; PELyon, PharmacoEpidemiology Lyon, 210 avenue Jean Jaurès, 69007, Lyon, France.
  • Van Ganse E; PELyon, PharmacoEpidemiology Lyon, 210 avenue Jean Jaurès, 69007, Lyon, France. eric.van-ganse@chu-lyon.fr.
Respir Res ; 22(1): 135, 2021 May 04.
Article in En | MEDLINE | ID: mdl-33947414
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Respiratory System Agents / Idiopathic Pulmonary Fibrosis / Indoles Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Res Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Respiratory System Agents / Idiopathic Pulmonary Fibrosis / Indoles Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Res Year: 2021 Document type: Article Affiliation country: Country of publication: